Health Canada Drug Approval Process: A Barrier to Personalized Care in Multiple Sclerosis

Affiliations

• ¹ Barlo MS Centre, Division of Neurology, Department of Medicine, St. Michael's Hospital, Toronto, Ontario, Canada.
• ² University of British Columbia, Vancouver, British Columbia, Canada.
• ³ Faculty of Medicine, Division of Neurology, University of British Columbia, Vancouver, British Columbia, Canada.
• ⁴ University of Calgary, Hotchkiss Brain Institute, Calgary, Alberta, Canada.
• ⁵ Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
• ⁶ Office of the Saskatchewan Multiple Sclerosis Clinical Research Chair, College of Medicine, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
• ⁷ London Health Sciences Centre, London, Ontario, Canada.
• ⁸ University of Ottawa Department of Medicine, and the Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
• ⁹ Montreal Neurological Institute and Hospital, Montreal, Québec, Canada.
• ¹⁰ CHU de Québec (Université Laval) & CIUSSS Capitale-Nationale - IRDPQ, Quebec City, Québec, Canada.
• ¹¹ Faculty of Medicine & Dentistry, University of Alberta, Edmonton, Alberta, Canada.
• ¹² Memorial University, St. John's, Newfoundland and Labrador, Canada.